BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Vertex Reports Third-Quarter 2017 Financial Results

  Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  30 min read
• Business

  PDL BioPharma to Announce Third Quarter 2017 Financial Results on November 2, 2017

  PDL BioPharma today announced that the Company will release its third quarter financial results for the period ended September 30, 2017, on Thursday, November 2, 2017, after market close.

  October 25, 2017

   · 

  2 min read
• Policy

  MabSpace Biosciences Submits Investigational New Drug Application for Its Second Generation PD-L1 Antibody With pH-Dependent Antigen Binding Property

  MabSpace Biosciences announced it has filed an IND application to CFDA on September 12th, 2017 for MSB2311, a second-generation PD-L1 antibody with pH-dependent antigen binding property.

  October 25, 2017

   · 

  2 min read
• Lone Star Bio

  CoorsTek Medical Announces the First Human Implantation of a New, State-of-the-Art Sacroiliac Fusion System

  CoorsTek Medical announced the first human implantation of a new generation of MIS Sacroiliac fusion implants.

  October 25, 2017

   · 

  2 min read
• Deals

  Endo Completes Divestiture of Grupo Farmaceutico SOMAR

  Endo International today announced the completion of the previously announced sale of Grupo Farmaceutico SOMAR to Advent International for a purchase price of approximately $124M.

  October 25, 2017

   · 

  2 min read
• Business

  Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results

  Novoheart Holdings Inc. today announced financial results for the three and twelve months ended June 30, 2017.

  October 25, 2017

   · 

  17 min read